Momenta Pharmaceuticals Announces Date of First Quarter 2015 Financial Results Conference Call and Webcast
April 15 2015 - 8:00AM
Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology
company specializing in the characterization and engineering of
complex drugs, will release its financial results for the first
quarter ended March 31, 2015 before the U.S. financial markets open
on Friday, May 1, 2015.
Management will host a conference call on that date at 10:00
a.m. EDT to discuss these results and provide an update on the
company. To access the call, please dial (877) 224-9084 (domestic)
or (720) 545-0022 (international) prior to the scheduled conference
call time and provide the access code 15401350. A live webcast of
the call will be available on the "Investors" section of the
company's website, www.momentapharma.com. Please go to the site at
least 15 minutes prior to the call in order to register, download,
and install any necessary software. An archived version of the
webcast will be posted on the Momenta website approximately two
hours after the call.
About Momenta Momenta Pharmaceuticals is a
biotechnology company specializing in the detailed structural
analysis of complex drugs and is headquartered in Cambridge, MA.
Momenta is applying its technology to the development of generic
versions of complex drugs, biosimilar and potentially
interchangeable biologics, and to the discovery and development of
novel therapeutics for oncology and autoimmune indications.
To receive additional information about Momenta, please visit
the website at www.momentapharma.com, which does not form a part of
this press release.
Our logo, trademarks, and service marks are the property of
Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or
service marks are property of their respective owners.
CONTACT: Sarah Carmody
Momenta Pharmaceuticals
1-617-395-5189
IR@momentapharma.com
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Apr 2023 to Apr 2024